RxDoctor Payments DataLook up a doctor →

Tulio Bertorini, MD

Neurology · Memphis, TNNPI 1760459168

Payments from drug & device makers

$1,032,998in general payments, 2019–2025

Across 864 payments — averaging $1195.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$489K
  • Mitsubishi Tanabe Pharma Development America, Inc.$202K
  • AstraZeneca$96K
  • Tanabe Pharma America, Inc.$62K
  • Catalyst Pharmaceuticals, Inc.$35K
  • Argenx US, Inc.$35K
  • plus $114K from 51 others
$1,353in research payments, 2019–2025

Across 5 payments — averaging $270.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring73$489,419
Mitsubishi Tanabe Pharma Development America, Inc.22$201,789
AstraZeneca(2 entities)105$95,510
Tanabe Pharma America, Inc.51$62,232
Catalyst Pharmaceuticals, Inc.4$35,465
Argenx US, Inc.41$34,802
UCB SA7$26,403
UCB, Inc.36$24,045
UCB Biosciences Inc.4$17,313
Sarepta Therapeutics, Inc.10$8,911
Takeda Pharmaceuticals U.S.A., Inc.8$8,807
Grifols USA, LLC10$6,880
Eli Lilly4$6,635
Grifols Biologicals LLC2$4,538
Sanofi19$2,964
AbbVie(2 entities)98$1,400
Teva Pharmaceuticals USA, Inc.72$910
Novartis54$660
Amgen(2 entities)19$373
Biogen12$354
Avanir Pharmaceuticals, Inc.15$287
Sunovion Pharmaceuticals Inc.19$264
EMD Serono, Inc.34$257
Janssen Research & Development, LLC2$241
Acadia Pharmaceuticals Inc16$212
EDW Pharma, Inc.1$201
Acorda Therapeutics, Inc9$170
Banner Life Sciences, LLC12$158
SK Life Science, Inc.8$151
Biohaven Pharmaceuticals, Inc.11$144
Genentech USA, Inc.10$143
Johnson & Johnson1$131
Bristol Myers Squibb8$116
Lundbeck LLC5$109
Alnylam Pharmaceuticals Inc.6$102
Supernus Pharmaceuticals, Inc.6$100
Lilly USA, LLC7$98
Pfizer4$78
Biohaven Pharmaceutical Holding Company Ltd.2$73
GE HealthCare5$66
Amneal Pharmaceuticals LLC5$61
GRT US Holding, Inc.3$59
Mallinckrodt Hospital Products Inc.3$57
Ipsen Biopharmaceuticals, Inc3$50
Eisai Inc.3$42
MDD US Operations, LLC3$38
Akcea Therapeutics, Inc.2$37
Boston Scientific1$22
E.r. Squibb & Sons, L.L.C.1$18
Jazz Pharmaceuticals Inc.1$16
Neurocrine Biosciences, Inc.1$15
NS Pharma, Inc.1$14
Harmony Biosciences LLC1$13
Sanofi-aventis U.S. LLC1$13
Adamas Pharmaceuticals, Inc.1$13
Assertio Therapeutics, Inc.1$12
Strongbridge US Inc.1$12

How this compares

$1,032,998 in reported general payments places this provider in the 95th percentile of 361 neurology providers in Tennessee.

See all neurology providers in Tennessee →

Medicare billing

Part B allowed, 2024
$4,716,260
Medicare patients
619
Services billed
118,958

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Memphis

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →